Freeline Therapeutics (FRLN)

AI Score

Unlock

6.49

0.01 (0.15%)

At close: Feb 16, 2024, 8:37 PM

Freeline Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020	Q3 2020	Q2 2020	Q1 2020	Q2 2019	Q1 2019	Q2 2018	Q1 2018
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Jun 30, 2019	Mar 31, 2019	Jun 30, 2018	Mar 31, 2018
Net Income	-49.93M	-52.74M	-61.07M	-88.97M	-100.67M	-116.66M	-132.18M	-140.39M	-143.77M	-137.87M	-114.56M	-96.32M	-71.72M	-60.22M	-43.66M	-43.6M	-30.12M	-16.64M	-8.32M
Depreciation & Amortization	1.45M	1.47M	1.52M	1.74M	2.04M	2.22M	2.36M	2.39M	2.36M	2.24M	1.99M	1.91M	1.71M	1.63M	1.26M	1.25M	870K	485K	242.5K
Stock-Based Compensation	3.98M	4.29M	4.67M	5.08M	5.89M	7.87M	9.55M	10.72M	11.24M	11.32M	8.42M	6.2M	4.2M	1.3M	1.06M	786.5K	421.75K	57K	28.5K
Other Working Capital	2.13M	2.75M	6.94M	3.62M	17.24M	18.68M	16.21M	22.54M	7.42M	2.51M	-4.24M	-8.13M	-8.62M	-7.13M	-4.31M	2.48M	2.83M	3.19M	1.59M
Other Non-Cash Items	-22.46M	-27.77M	-25.33M	-4.98M	-4.92M	371K	216K	148K	78K	79K	13.12M	13.11M	13.04M	13.04M	n/a	n/a	n/a	n/a	n/a
Deferred Income Tax	-156K	-156K	-156K	-156K	35K	35K	35K	-171K	-364K	-364K	-13.4M	-13.2M	-13.04M	-13.04M	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	2.87M	4.16M	10.29M	9.07M	21.97M	22.98M	20.1M	19.74M	6.95M	-7.21M	-6.8M	-6.68M	-9M	384K	-2.78M	2.51M	2.86M	3.21M	1.61M
Operating Cash Flow	-64.24M	-70.74M	-70.08M	-78.22M	-75.66M	-83.18M	-99.92M	-107.56M	-123.5M	-131.8M	-111.23M	-94.97M	-74.81M	-56.91M	-44.12M	-39.05M	-25.97M	-12.89M	-6.44M
Capital Expenditures	-4.55M	-6.72M	-6.88M	-7.01M	-3.75M	-2.55M	-2.52M	-4.27M	-5.37M	-4.62M	-4.52M	-2.8M	-1.82M	-2.35M	-2.07M	-3.39M	-2.63M	-1.87M	-937.25K
Cash Acquisitions	24.15M	24.2M	24.2M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	112.43K	66.03K	n/a	n/a	n/a	n/a	n/a	n/a	126K	126K	411K	411K	1.04M	1.8M	1.51M	3.39M	2.63M	1.87M	937.25K
Investing Cash Flow	19.71M	17.54M	17.32M	-7.01M	-3.75M	-2.55M	-2.52M	-4.27M	-5.25M	-4.5M	-4.11M	-2.39M	-1.54M	-2.06M	-2.07M	-3.39M	-2.63M	-1.87M	-937.25K
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	251.27K	53.75K	2.14M	27.39M	26.21M	26.33M	24.26M	-983.84K	260.16K	174.87M	241.44M	242.62M	242.46M	67.86M	1.18M	n/a	n/a	n/a	n/a
Financial Cash Flow	67.36K	25.18K	2.19M	27.52M	26.35M	26.35M	24.26M	-984K	260K	174.87M	241.44M	242.62M	242.46M	67.86M	1.18M	n/a	n/a	n/a	n/a
Net Cash Flow	-37.91M	-52.79M	-59.37M	-70.46M	-70.75M	-74.87M	-82.73M	-112.51M	-114.46M	58.75M	143.94M	157M	192.26M	61.95M	7.82M	33.02M	18.46M	3.9M	1.95M
Free Cash Flow	-68.79M	-77.46M	-76.96M	-85.24M	-79.42M	-85.73M	-102.44M	-111.83M	-128.87M	-136.43M	-115.75M	-97.76M	-76.63M	-59.25M	-46.19M	-42.43M	-28.6M	-14.76M	-7.38M